BSE filing, NSE: ISLCONSUL. Summary written from the filing by ALFA Finder's alert engine.
ISL Consulting Ltd: key numbers
- Share price
- ₹11.00
- Market cap
- ₹26.40 Cr
- Revenue (annual)
- ₹18.64 Cr
- Net profit (annual)
- ₹-2.04 Cr
- P/E (TTM)
- -80.9×Sector 19.7×
- Promoter holding
- 60.06%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ISL Consulting Ltd
All →ISL Consulting Board Meeting Date
ISL Consulting Ltd scheduled a board meeting for November 4, 2026. The agenda covers approval of Q1 and H1 FY27 standalone results and related party transactions.
ISL Consulting Management Change
ISL Consulting Limited has appointed M/s. G M C A & CO. as Statutory Auditors for a five-year term. The appointment is effective from August 31, 2026.
- Execution
- 60 months
ISL Consulting Other Announcement
ISL Consulting Limited has appointed M/s G M C A & CO. as Statutory Auditors for a five-year term. The appointment was approved by shareholders at the Annual General Meeting.
- Execution
- 5 years
ISL Consulting Annual General Meeting
ISL Consulting Limited held its 34th Annual General Meeting on September 29, 2026. Shareholders considered the adoption of audited financial statements, director re-appointment, and statutory auditor appointment.
ISL Consulting Annual Report
ISL Consulting filed its 34th Annual Report for FY 2025-26 under Regulation 34. The filing also encloses the notice for the 34th AGM on 29 September 2026.
ISL Consulting Annual General Meeting
ISL Consulting Limited has announced the closure of its Register of Members and Share Transfer Books from September 24, 2026, to September 29, 2026, for its AGM.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.